No Data
Haisco Pharmaceutical Group Clarifies No Financial Assistance in Share Issuance
Gelonghui Announcement Selection︱ Baiwei Storage: Net income for the year 2024 is 0.176 billion yuan, a year-on-year increase of 128.14%; Shanghai DragonNet Technology: No business cooperation with DeepSeek at present.
【Hot News】Shenzhen Gongjin Electronics (603118.SH): Lidar products are not the company's main Business, accounting for less than 1% of the company's revenue. Ningbo Henghe Precision Industry (300539.SZ): Not involved in humanoid robot Business. Shanghai DragonNet Technology (300245.SZ): No current Business cooperation with DeepSeek. Wuxi Boton Technology (300031.SZ): Recently engaged in friendly exchanges and technical discussions with Yushu Technology, exploring innovative applications and implementations of industrial robot technology. 【Project Investment】Guangdong Guanghua Sci-Tech (002741.SZ): Plans to invest in the construction of an annual output of 0.1 million tons of high-performance Lithium Battery materials project.
Haisco Pharmaceutical Group (002653.SZ): Plans to raise no more than 1.365 billion yuan through a private placement to invest in new drug research and development projects, among others.
On February 27th, Gelonghui reported that Haisco Pharmaceutical Group (002653.SZ) announced plans to issue A-shares to specific objects for the year 2025, with the number of shares issued not exceeding 70,000,000 shares (inclusive), which, based on the company's total share capital, is not more than 30% of the total share capital before this issuance. The total amount raised from the issuance of shares to specific objects will not exceed 1.365 billion yuan (inclusive), with a net amount of approximately 0.965 billion yuan intended for investment in new drug research and development projects, and 0.4 billion yuan for replenishing working capital.
Are Investors Undervaluing Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653) By 39%?
Recent 3.7% Pullback Would Hurt Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653) Insiders
Express News | Haisco Pharma Plans to Set up Subsidiary Hexgen Pharmaceutical in Delaware in U.S. for Business Development
What Haisco Pharmaceutical Group Co., Ltd.'s (SZSE:002653) 26% Share Price Gain Is Not Telling You
